Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea.
We reviewed 242 allogeneic hematopoietic stem cell transplantation (HSCT) recipients retrospectively over a 2-year period (January 1998-December 1999) in order to analyze the characteristics and assess the outcomes of infectious complications in patients after HSCT in Korea. Bacteria were the major pathogens before engraftment, and viral and fungal infections predominated during the post-engraftment period. Varicella zoster virus was the most common viral pathogen after engraftment. Cytomegalovirus disease occurred mainly in the late-recovery phase. The frequency of mold infection was higher than that of yeast. There was a relatively high incidence of tuberculosis (3.0%) and Pneumocystis carinii pneumonia (6.5%). One case of death by measles confirmed by autopsy was also noted. Overall, cumulative mortality was 43% (104/242), and 59.6% of these deaths (62/104) were infection-related. Allogeneic HSCT recipients from unrelated donors were prone to infectious complication and higher mortality than those from matched sibling (17/39 (43.6%) vs 45/203 (22.2%), respectively; P<0.01; odd ratio 2.5; 95% confidence interval 1.2-5.1). As infection was the main post-HSCT complication in our data, more attention should be given to the management of infections in HSCT recipients.
Yoo
J-H
JH
Department of Internal Medicine, The Catholic Hematopoietic Stem Cell Transplantion Center, College of Medicine, The Catholic University of Korea, Seoul, Korea. jhyoo@catholic.ac.kr
Lee
D-G
DG
Choi
S M
SM
Choi
J-H
JH
Park
Y-H
YH
Kim
Y-J
YJ
Kim
H-J
HJ
Lee
S
S
Kim
D-W
DW
Lee
J-W
JW
Min
W-S
WS
Shin
W-S
WS
Kim
C-C
CC
D000293:Adolescent; D000328:Adult; D001424:Bacterial Infections / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007239:Infections / Q000453:epidemiology*; D007723:Korea; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000453:epidemiology; D009190:Myelodysplastic Syndromes / Q000628:therapy; D012189:Retrospective Studies; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000401:mortality; D016019:Survival Analysis; D016896:Treatment Outcome; D014777:Virus Diseases / Q000453:epidemiology*